Published in Trop Med Int Health on September 01, 2000
In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon. Antimicrob Agents Chemother (2003) 1.72
Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children. Antimicrob Agents Chemother (2003) 1.24
Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon. PLoS One (2013) 1.00
Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (2004) 0.80
Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol Biochem Parasitol (1998) 2.08
In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg (1996) 1.55
Desipramine or cyproheptadine for reversing chloroquine resistance? Lancet (1990) 1.52
Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. Gene (1998) 1.37
In vitro antimalarial activity of limonoids from Khaya grandifoliola C.D.C. (Meliaceae). J Ethnopharmacol (2000) 1.37
Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli. Mol Biochem Parasitol (2001) 1.28
Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. J Infect Dis (2000) 1.22
Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaoundé, Cameroon. Bull World Health Organ (1999) 1.21
Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Clin Infect Dis (1998) 1.12
Inland valley rice production systems and malaria infection and disease in the savannah of Côte d'Ivoire. Trop Med Int Health (2003) 1.11
Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. Am J Trop Med Hyg (1996) 1.10
In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum. Antimicrob Agents Chemother (1999) 1.07
False chloroquine resistance in Africa. Lancet (1997) 1.06
[Malaria in military personnel: the case of the Ivory Coast in 2002-2003]. Med Trop (Mars) (2003) 1.05
Plasmodium falciparum: detection of P-glycoprotein in chloroquine-susceptible and chloroquine-resistant clones and isolates. Exp Parasitol (1995) 1.02
Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Exp Parasitol (1995) 1.00
In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg (1999) 0.99
In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera. J Clin Microbiol (1999) 0.99
[Malaria in health centres in the southern districts of Brazzaville, Congo]. Bull Soc Pathol Exot (2008) 0.97
Chemoresistance of P. falciparum in urban areas of Yaounde, Cameroon. Part 1: Surveillance of in vitro and in vivo resistance of Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaounde, Cameroon. Trop Med Int Health (2000) 0.95
[Chemosusceptibility analysis of Plasmodium falciparum imported from Comoros to Marseilles, France in 2001-2003]. Med Mal Infect (2005) 0.93
Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. Am J Trop Med Hyg (1994) 0.91
Detection of Plasmodium ovale malaria parasites by species-specific 18S rRNA gene amplification. Mol Cell Probes (1997) 0.90
Heterogeneity in the circumsporozoite protein gene of Plasmodium malariae isolates from sub-Saharan Africa. Mol Biochem Parasitol (1998) 0.90
Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg (1996) 0.90
Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans. Clin Pharmacol Ther (1992) 0.89
Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil; a study conducted in 1996 in the French Army. Trans R Soc Trop Med Hyg (1999) 0.89
Diagnosis of Plasmodium malariae infection by the polymerase chain reaction. Trans R Soc Trop Med Hyg (1997) 0.88
[Senegal and malaria. True prophylactic failure of mefloquine]. Presse Med (2002) 0.87
In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine. Antimicrob Agents Chemother (1991) 0.87
Evaluating the efficacy of chloroquine in febrile Guinean children infected with Plasmodium falciparum by a simplified in vivo test. Bull World Health Organ (1992) 0.87
Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000. Euro Surveill (2002) 0.87
In vitro activities of novel catecholate siderophores against Plasmodium falciparum. Antimicrob Agents Chemother (1996) 0.87
Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients. Eur J Clin Pharmacol (1994) 0.86
Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria. Am J Trop Med Hyg (1999) 0.86
Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients. Am J Trop Med Hyg (2001) 0.85
Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans. Clin Pharmacol Ther (1995) 0.85
Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. J Clin Microbiol (1998) 0.84
DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France. Trans R Soc Trop Med Hyg (1997) 0.82
[Experimental study of the compatibility between Schistosoma haematobium and two species of Bulinus in Cameroon]. Bull Soc Pathol Exot (2004) 0.82
[Epidemiological study of foci of S. intercalatum schistosomiasis in Eseka and Edea (Cameroon). Effects of treatment with praziquantel]. Arzneimittelforschung (1981) 0.82
[An epidemiological study of human filariasis : loaiasis, dipetalonemiasis, tetrapetalonemiasis, in Douala fisherman of the river Wouri estuary (Cameroon) (author's transl)]. Rev Epidemiol Sante Publique (1980) 0.82
Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections. Antimicrob Agents Chemother (1997) 0.81
Pharmacokinetics/Pharmacodynamics findings after repeated administration of ARTESUNATE thermostable suppositories (RECTOCAPS) in Vietnamese patients with uncomplicated malaria. Eur J Drug Metab Pharmacokinet (2006) 0.80
The relationship between body weight and tolerance to mefloquine prophylaxis in non-immune adults: results of a questionnaire-based study. Ann Trop Med Parasitol (2004) 0.80
Halofantrine resistance in African countries. Lancet (1993) 0.80
[In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil]. Bull Soc Pathol Exot (1999) 0.79
[Evaluation of Plasmodium falciparum resistance to antimalarial drugs]. Med Trop (Mars) (1995) 0.79
Evaluation of a new sulfadoxine sensitivity assay in vitro for field isolates of Plasmodium falciparum. Trans R Soc Trop Med Hyg (2001) 0.79
Plasmodium falciparum: pfcrt and DHFR mutations are associated with failure of chloroquine plus proguanil prophylaxis in travelers. J Infect Dis (2001) 0.79
[Severe forms of malaria in children in a general hospital pediatric department in Yaounde, Cameroon]. Bull Soc Pathol Exot (1999) 0.78
Plasmodium vivax: rapid detection by polymerase chain reaction and restriction fragment length polymorphism of the key mutation in dihydrofolate reductase-thymidylate synthase gene associated with pyrimethamine resistance. Exp Parasitol (1998) 0.78
Absence of effect of retinol on the in vitro development of Plasmodium falciparum. Int J Vitam Nutr Res (1992) 0.77
Uptake of mefloquine enantiomers into uninfected and malaria-infected erythrocytes. Drug Metab Dispos (1996) 0.77
Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates. Mol Cell Probes (1995) 0.77
[In vivo evaluation of sulfadoxine-pyrimethamine efficacy during uncomplicated falciparum malaria in children of Yopougon (Abidjan, Côte d'Ivoire)]. Bull Soc Pathol Exot (2004) 0.77
In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire). Afr Health Sci (2010) 0.76
Amodiaquine as the first-line treatment of malaria in Yaoundé, Cameroon: presumptive evidence from activity in vitro and cross-resistance patterns. Trans R Soc Trop Med Hyg (1998) 0.76
Malarone-donation programme in Africa. Lancet (1998) 0.75
Surveillance of antifolate-resistant malaria. Lancet (1998) 0.75
Antimalarial chemoprophylaxis for west Africa. Lancet (1993) 0.75
Confused malaria chemoprophylaxis. Lancet (1994) 0.75
Inefficacy of amodiaquine against chloroquine-resistant malaria. Lancet (1991) 0.75
[Dynamics of intestinal schistosomiasis in Cameroon: evolution of transmission in the mixed zone of Nkolmébanga, Lékié]. Med Trop (Mars) (2004) 0.75
[Mechanisms and epidemiology of resistances to antimalarials]. C R Seances Soc Biol Fil (1996) 0.75
[Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions]. Bull Soc Pathol Exot (1999) 0.75
Human pharmacokinetics of chloroquine and proguanil delivered in a single capsule for malaria chemoprophylaxis. Trop Med Parasitol (1995) 0.75
[Imported malaria in 2000 in 2 northern Paris hospitals]. Bull Soc Pathol Exot (2003) 0.75
[Malaria epidemic during a military-humanitarian mission in Africa]. Med Trop (Mars) (1997) 0.75
Analysis of Plasmodium falciparum multidrug-resistance (pfmdr1) gene mutation by hairpin-dependent cleavage fragment length polymorphism. Mol Biochem Parasitol (1997) 0.75
[Cerebral malaria in children in Yaounde, Cameroon. Clinical, paraclinical and developmental aspects]. Ann Soc Belg Med Trop (1994) 0.75
[Sensitivity of S. intercalatum to praziquantel (author's transl)]. Med Trop (Mars) (1982) 0.75
[Prevention and treatment of malaria: in vitro evaluation of new compounds]. Ann Pharm Fr (2001) 0.75
[Epidemiologic study of intestinal helminthiasis in the valley of the Guerléo River (North Cameroon)]. Bull Soc Pathol Exot Filiales (1983) 0.75
[Morbidity and histo-endoscopic study of Schistosoma mansoni bilharziasis in Nkolbisson (Cameroon)]. Bull Soc Pathol Exot (1993) 0.75
[Antimalarial chemoprophylaxis in the French army: development from 1986 to 2001]. Med Trop (Mars) (2001) 0.75
[Value of rectoscopy in the diagnosis of Schistosoma mansoni bilharziasis. Study at Nkolbisson-Cameroon]. Med Trop (Mars) (1993) 0.75
[Plasma levels of halofantrine during two therapeutic sessions at a 7 day interval]. Presse Med (1995) 0.75
Efficacy of low-dose halofantrine for second treatment of uncomplicated falciparum malaria. Lancet (1997) 0.75
[Malaria and post operative fever in the University Hospital Center of Yaounde (Cameroon)]. Med Trop (Mars) (1993) 0.75
[Vectorial fauna at the site of the future dam at Memve'ele(Cameroon)]. Bull Soc Pathol Exot (1994) 0.75
[Mefloquine and halofantrine, new therapeutic drugs of malaria]. Rev Med Interne (1991) 0.75
Chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet (1992) 0.75
[Contribution of molecular genetics to the understanding of chemoresistance of Plasmodium falciparum]. Bull Soc Pathol Exot (1992) 0.75
[Drug sensitivity of falciparum malaria imported into France in 1995]. Bull Soc Pathol Exot (1997) 0.75
[Malaria research at the IMTSSA le Pharo]. Med Trop (Mars) (2001) 0.75
[Periportal fibrosis in Schistosoma mansoni schistosomiasis. An ultrasonographic study in the area of Nkolbisson (Cameroon)]. J Radiol (1993) 0.75
[Candidiasis and AIDS in Yaounde]. Bull Soc Pathol Exot (1991) 0.75